Life sciences news
-
Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19
Tuesday April 5th 2022
Read more
-
Kantify announces its new breakthrough AI technology for drug discovery
Thursday March 31st 2022
Read more
-
V-Bio Ventures raises EUR 110 million for its second fund and expands team
Thursday March 31st 2022
Read more
-
Biotalys appoints Carlo Boutton as Chief Scientific Officer
Thursday March 31st 2022
Read more
-
BioStrand announces acquisition by IPA
Wednesday March 30th 2022
Read more
-
miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer
Wednesday March 30th 2022
Read more
-
Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth
Tuesday March 29th 2022
Read more
-
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
Tuesday March 29th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
2021 was a record year for Flanders’ exports
Tuesday March 29th 2022
Read more
-
eTheRNA Manufacturing announces new LNP formulation development and production service
Tuesday March 29th 2022
Read more
-
Jyseleca® approved in Japan for ulcerative colitis
Monday March 28th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
